Company Filing History:
Years Active: 2024
Title: Chenggang Li: Innovator in Antibody-Drug Conjugates
Introduction
Chenggang Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions. His work focuses on antibody-drug conjugates, which are crucial in targeted cancer therapies.
Latest Patents
Chenggang Li holds a patent for an "Anti-B7H3 antibody-drug conjugate and use thereof." This invention provides an antibody-drug conjugate specifically binding to B7H3, along with a pharmaceutical composition that includes this conjugate. The patent also outlines methods for utilizing this antibody-drug conjugate in therapeutic applications.
Career Highlights
Chenggang Li is associated with Duality Biologics (Suzhou) Co., Ltd., where he continues to advance his research and development efforts. His expertise in antibody-drug conjugates positions him as a key player in the biotechnology sector.
Collaborations
Chenggang Li collaborates with notable colleagues, including Zhongyuan Zhu and Chen Zhong. Their combined efforts contribute to the innovative research and development at Duality Biologics.
Conclusion
Chenggang Li's work in the field of antibody-drug conjugates exemplifies the innovative spirit of modern biotechnology. His contributions are paving the way for new therapeutic options in cancer treatment.